-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UEqNjA5GHo8pHLXsAfwYWnURX5aCPOPHd7lNCYNmUPXQatc+Y1W24lSjLPMobD2F 7aui9fFyl9xpnH/k+65PRA== 0000318771-98-000002.txt : 19980408 0000318771-98-000002.hdr.sgml : 19980408 ACCESSION NUMBER: 0000318771-98-000002 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 19971231 FILED AS OF DATE: 19980407 SROS: NYSE SROS: PCX FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: SEC FILE NUMBER: 001-09813 FILM NUMBER: 98588492 BUSINESS ADDRESS: STREET 1: 460 POINT SAN BRUNO BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 4152251000 MAIL ADDRESS: STREET 1: 460 POINT SAN BRUNO BLVD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 10-K/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1997 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-9813 GENENTECH, INC. A Delaware Corporation 94-2347624 (I.R.S. employer identification number) 1 DNA Way South San Francisco, California 94080-4990 (650) 225-1000 Securities registered pursuant to Section 12(b) of the Act: ============================================================================== Title of Each Class Name of Each Exchange on Which Registered - ------------------------------------------------------------------------------ Common Stock $.02 par value New York Stock Exchange Callable Putable Common Stock Pacific Exchange $.02 par value ============================================================================== Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] The approximate aggregate market value of voting stock held by nonaffiliates of the registrant is $2,143,366,690 as of February 13, 1998. (A) Number of shares of Common Stock outstanding as of February 13, 1998: 76,621,009 Number of shares of Callable Putable Common Stock outstanding as of February 13, 1998: 48,148,527 Documents incorporated by reference: PARTS INCORPORATED DOCUMENT BY REFERENCE (1) Annual Report to stockholders for the year ended II December 31, 1997 (specified portions) (2) Definitive Proxy Statement with respect to the 1998 III Annual Meeting of Stockholders filed by Genentech, Inc. (SEC file No. 1-9813) with the Securities and Exchange Commission (hereinafter referred to as "Proxy Statement") - ------------------------------------------------------------------------------- (A) Excludes 92,386,281 shares of Common Stock and Callable Putable Common Stock held by Directors, Officers and stockholders whose ownership exceeds five percent of either the Common Stock or Callable Putable Common Stock outstanding at February 13, 1998 (the holdings of FMR Corp., Goldman Sachs & Co. and The Goldman Sachs Group, L.P. were calculated based on their holdings as of December 31, 1997). Exclusion of shares held by any person should not be construed to indicate that such person possesses the power, direct or indirect, to direct or cause the direction of the management or policies of the registrant, or that such person is controlled by or under common control with the registrant AMENDMENT NO. 1 The undersigned registrant hereby amends its Annual Report on Form 10-K for the fiscal year ended December 31, 1997, to include Restated Financial Data Schedules for the following periods as a result of its adoption of Statement of Financial Accounting Standards No. 128, Earnings Per Share: - Year Ended December 31, 1996. - Year Ended December 31, 1995. - Quarter Ended March 31, 1997. - Quarter Ended June 30, 1997. - Quarter Ended September 30, 1997. - Quarter Ended March 31, 1996. - Quarter Ended June 30, 1996. - Quarter Ended September 30, 1996. Accordingly, the undersigned hereby amends the following items, financial statements, exhibits or other reports of its Annual Report on Form 10-K for the year ended December 31, 1997, as set forth below: PART IV ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K (a) 1. Index to Financial Statements The following Financial Statements and supplementary data are included in the Company's 1997 Annual Report to Stockholders and are incorporated herein by reference pursuant to Item 8 of this Form 10-K. Page(s) in 1997 Annual Report to Stockholders ---------------------- Consolidated Statements of Income for each of the three years in the period ended December 31, 1997 42 Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 1997 43 Consolidated Balance Sheets at December 31, 1997 and 1996 44 Consolidated Statements of Stockholders' Equity for each of the three years in the period ended December 31, 1997 45 Notes to Consolidated Financial Statements 46-60 Report of Ernst & Young LLP, Independent Auditors 61 Quarterly Financial Data (unaudited) 61 2. Financial Statement Schedule The following schedule is filed as part of this Form 10-K: Schedule II- Valuation and Qualifying Accounts for each of the three years in the period ended December 31, 1997. All other schedules are omitted because they are not applicable, or not required, or because the required information is included in the consolidated financial statements or notes thereto. 3. Exhibits Exhibit No. Description ----------- ----------- 3.1 Certificate of Incorporation.(1) 3.2 Amended Certificate of Incorporation.(5) 3.3 Restated By-Laws.(3) 4.1 Indenture, dated March 27, 1987 ("Indenture") for U.S. $150,000,000 5% Convertible Subordinated Debentures due 2002.(2) 4.2 First Supplemental to Indenture, dated August 17, 1990.(3) 4.3 Second Supplemental to Indenture, dated October 18, 1995. (7) 10.1 Patent License Agreement with Columbia University dated October 12, 1988.(2) 10.2 Amended and Restated Contract for the Sale and Distribution of Protropin dated as of March 1, 1991.(4) 10.3 Agreement and Plan of Merger, dated as of May 23, 1995, as amended and restated, among the Company, Roche Holdings, Inc. and HLR (U.S.) II, Inc. with exhibits.(5) 10.4 Amended and Restated Governance Agreement, dated October 25, 1995, between the Company and Roche Holdings, Inc.(5) 10.5 Agreement between Genentech and F. Hoffman-La Roche Ltd regarding commercialization of Genentech's products outside the United States dated as of October 25, 1995.(5) 10.6 Guaranty Agreement between Genentech and Roche Holding, Ltd dated as of October 25, 1995.(5) 10.7 Guiding Principles for the Genentech/Roche Relationship.(8) 13.1 1997 Annual Report to Stockholders.(11) 23.1 Consent of Ernst & Young LLP, Independent Auditors.(11) 27.1 Financial Data Schedule - year ended December 31, 1997.(11) 27.2 Restated Financial Data Schedule - year ended December 31, 1996.(12) 27.3 Restated Financial Data Schedule - year ended December 31, 1995.(12) 27.4 Restated Financial Data Schedule - quarter ended March 31, 1997.(12) 27.5 Restated Financial Data Schedule - quarter ended June 30, 1997.(12) 27.6 Restated Financial Data Schedule - quarter ended September 30, 1997.(12) 27.7 Restated Financial Data Schedule - quarter ended March 31, 1996.(12) 27.8 Restated Financial Data Schedule - quarter ended June 30, 1996.(12) 27.9 Restated Financial Data Schedule - quarter ended September 30, 1996.(12) 28.1 Description of the Company's capital stock.(1) 99.1* 1984 Incentive Stock Option Plan, as amended and restated as of October 16, 1996.(8) 99.2* 1984 Non-Qualified Stock Option Plan, as amended and restated as of October 16, 1996.(8) 99.3* Restated Relocation Loan Program.(4) 99.4* Restated 401(k) Plan.(7) 99.5* 1990 Stock Option/Stock Incentive Plan, as amended and restated as of October 16, 1996.(8) 99.6* Supplemental Plan.(4) 99.7* 1994 Stock Option Plan, as amended and restated as of October 16, 1996.(8) 99.8* 1996 Stock Option/Stock Incentive Plan, as amended and restated as of October 16, 1996.(8) 99.9* Deferred Compensation Plan.(8) 99.10* 1991 Employee Stock Plan, as amended April 10, 1997.(9) 99.11* Incentive Units Plan.(10) * As required by Item 14(a)(3) of Form 10-K, the Company identifies this Exhibit as a management contract or compensatory plan or arrangement of the Company. - -------------------- (1) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1986 and incorporated herein by reference. (2) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1987 and incorporated herein by reference. (3) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1990 and incorporated herein by reference. (4) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1991 and incorporated herein by reference. (5) Filed as an exhibit to Form S-4 dated October 25, 1995 (registration statement no. 33-59949) and incorporated herein by reference. (6) Filed as an exhibit to Form S-8 dated October 25, 1995 (registration statement no. 33-59949-01) and incorporated herein by reference. (7) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1995 and incorporated herein by reference. (8) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1996 and incorporated herein by reference. (9) Filed as an exhibit to the Quarterly Report on Form 10-Q filed for the quarterly period ended March 31, 1997 and incorporated herein by reference. (10) Filed as an exhibit to the Quarterly report on Form 10-Q filed for the quarterly period ended June 30, 1997 and incorporated herein by reference. (11) Filed as an exhibit to Annual Report on Form 10-K for the year ended December 31, 1997 and incorporated herein by reference. (12) Filed with this document. (b) Reports on Form 8-K There were no reports on Form 8-K filed for the quarter ended December 31, 1997. SCHEDULE II GENENTECH, INC. VALUATION AND QUALIFYING ACCOUNTS Years Ended December 31, 1997, 1996 and 1995 (in thousands)
Additions Balance at Charged to Balance at Beginning of Costs and End of Period Expenses Deductions(1) Period ---------- ---------- ---------- ---------- Allowance for doubtful accounts and returns: Year Ended December 31, 1997: $ 7,869 $ 13,976 $ (7,310) $ 14,535 ========== ========== ========== ========== Year Ended December 31, 1996: $ 6,672 $ 12,320 $ (11,123) $ 7,869 ========== ========== ========== ========== Year Ended December 31, 1995: $ 4,422 $ 10,972 $ (8,722) $ 6,672 ========== ========== ========== ========== Inventory reserves: Year Ended December 31, 1997: $ 9,279 $ 5,901 $ (3,125) $ 12,055 ========== ========== ========== ========== Year Ended December 31, 1996: $ 6,909 $ 4,950 $ (2,580) $ 9,279 ========== ========== ========== ========== Year Ended December 31, 1995: $ 13,008 $ 3,690 $ (9,789) $ 6,909 ========== ========== ========== ========== Reserve for non-marketable equity securities: Year Ended December 31, 1997: $ 4,990 $ 500 $ - $ 5,490 ========== ========== ========== ========== Year Ended December 31, 1996: $ 5,092 $ - $ (102) $ 4,990 ========== ========== ========== ========== Year Ended December 31, 1995: $ 4,623 $ 469 $ - $ 5,092 ========== ========== ========== ========== (1) Represents amounts written off or returned against the allowance or reserves.
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this amendment to be signed on its behalf by the undersigned, thereunto duly authorized. GENENTECH, INC. Registrant Date: April 3, 1998 By: /S/JOHN M. WHITING ---------------------------------- John M. Whiting Controller and Chief Accounting Officer (Principal Accounting Officer) Pursuant to the requirements of the Securities Exchange Act of 1934, this amendment has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated: Signature Title Date --------- ----- ---- Principal Executive Officer: /S/ARTHUR D. LEVINSON President, Chief Executive April 3, 1998 - --------------------------- Officer and Director Arthur D. Levinson Principal Financial Officer: /S/LOUIS J. LAVIGNE, JR. Executive Vice President April 3, 1998 - --------------------------- and Chief Financial Officer Louis J. Lavigne, Jr. Director: HERBERT W. BOYER* Director April 3, 1998 - --------------------------- Herbert W. Boyer JONATHAN K.C. KNOWLES* Director April 3, 1998 - --------------------------- Jonathan K.C. Knowles FRANZ B. HUMER* Director April 3, 1998 - --------------------------- Franz B. Humer LINDA F. LEVINSON* Director April 3, 1998 - --------------------------- Linda F. Levinson J. RICHARD MUNRO* Director April 3, 1998 - --------------------------- J. Richard Munro DONALD L. MURFIN* Director April 3, 1998 - --------------------------- Donald L. Murfin JOHN T. POTTS, JR.* Director April 3, 1998 - --------------------------- John T. Potts, Jr. C. THOMAS SMITH, JR.* Director April 3, 1998 - --------------------------- C. Thomas Smith, Jr. DAVID S. TAPPAN, JR.* Director April 3, 1998 - --------------------------- David S. Tappan, Jr. *by: /S/JOHN M. WHITING - --------------------------- (John M. Whiting, Attorney-in-Fact) INDEX OF EXHIBITS FILED WITH FORM 10-K/A FOR THE YEAR ENDED DECEMBER 31, 1997
Exhibit No. Description - ----------- ----------- 27.2 Restated Financial Data Schedule - year ended December 31, 1996. 27.3 Restated Financial Data Schedule - year ended December 31, 1995. 27.4 Restated Financial Data Schedule - quarter ended March 31, 1997. 27.5 Restated Financial Data Schedule - quarter ended June 30, 1997. 27.6 Restated Financial Data Schedule - quarter ended September 30, 1997. 27.7 Restated Financial Data Schedule - quarter ended March 31, 1996. 27.8 Restated Financial Data Schedule - quarter ended June 30, 1996. 27.9 Restated Financial Data Schedule - quarter ended September 30, 1996.
2
EX-27 2 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS, CONSOLIDATED STATEMENTS OF INCOME AND CONSOLIDATED STATEMENTS OF CASH FLOWS INCLUDED IN THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 1,000 YEAR DEC-31-1996 DEC-31-1996 207,264 951,816 205,481 7,869 91,943 955,084 906,267 320,100 2,226,372 249,951 150,000 0 0 2,428 1,798,631 2,226,372 582,829 968,678 104,527 104,527 471,143 9,887 5,010 147,935 29,587 118,348 0 0 0 118,348 0.98 0.95 Represents Basic earnings per share. Restated to reflect the Company's adoption of FAS 128.
EX-27 3 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "Earnings Per Share" (FAS 128), AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS, CONSOLIDATED STATEMENTS OF INCOME AND CONSOLIDATED STATEMENTS OF CASH FLOWS INCLUDED IN THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 1,000 YEAR DEC-31-1995 DEC-31-1995 137,043 959,771 178,832 6,672 93,648 1,045,414 772,405 268,751 2,010,995 233,444 150,000 0 0 2,385 1,599,662 2,010,995 635,263 917,845 97,930 97,930 363,049 10,972 7,940 172,273 25,841 146,432 0 0 0 146,432 1.24 1.20 Represents Basic earnings per share. Restated to reflect the Company's adoption of FAS 128.
EX-27 4 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1997, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 3-MOS DEC-31-1997 MAR-31-1997 149,817 1,016,268 205,561 0 93,667 1,005,605 950,783 332,888 2,282,166 248,464 150,000 0 0 2,447 1,857,368 2,282,166 154,213 257,285 27,685 27,685 122,743 0 988 43,888 12,289 31,599 0 0 0 31,599 0.26 0.25 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OR STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
EX-27 5 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 1997, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 6-MOS DEC-31-1997 JUN-30-1997 207,731 949,158 209,622 0 99,667 1,041,072 981,366 347,424 2,331,282 248,952 150,000 0 0 2,463 1,904,347 2,331,282 299,231 490,778 53,252 53,252 233,633 0 1,904 76,935 21,542 55,393 0 0 0 55,393 0.45 0.44 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OR STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
EX-27 6 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 1997, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 9-MOS DEC-31-1997 SEP-30-1997 194,951 1,062,800 207,805 0 98,893 1,159,590 1,025,842 362,063 2,451,023 269,745 150,000 0 0 2,472 1,983,257 2,451,023 441,537 739,695 79,817 79,817 351,779 0 2,446 115,149 27,634 87,515 0 0 0 87,515 0.71 0.69 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OR STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
EX-27 7 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1996, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 3-MOS DEC-31-1996 MAR-31-1996 138,880 1,008,933 174,865 0 88,853 1,064,397 796,015 281,554 2,065,668 224,377 150,000 0 0 2,403 1,662,909 2,065,668 152,337 242,884 25,879 25,879 115,633 0 1,559 47,771 9,554 38,217 0 0 0 38,217 0.32 0.31 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OR STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
EX-27 8 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 1996, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 1,000 6-MOS DEC-31-1996 JUN-30-1996 118,830 1,026,479 189,829 0 85,447 1,071,592 829,420 294,936 2,107,294 221,697 150,000 0 0 2,413 1,707,838 2,107,294 300,642 486,646 53,032 53,032 228,236 0 2,892 89,457 29,521 59,936 0 0 0 59,936 0.50 0.48 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OF STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
EX-27 9 WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
5 [LEGEND] THIS SCHEDULE HAS BEEN RESTATED TO REFLECT THE COMPANY'S ADOPTION OF STATEMENT OF FINANCIAL ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE" (FAS 128) AND CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 1996, AND THE QUARTERLY FINANCIAL DATA FROM THE COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1997, AND ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND THE NOTES THERETO. [/LEGEND] 9-MOS DEC-31-1996 SEP-30-1996 146,039 1,030,120 196,413 0 92,045 1,000,099 857,450 308,391 2,170,985 216,490 150,000 0 0 2,423 1,777,001 2,170,985 443,105 738,353 77,868 77,868 343,008 0 3,986 138,598 27,720 110,878 0 0 0 110,878 0.92 0.89 ACCOUNTS RECEIVABLE ARE PRESENTED NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS IN THE CONDENSED CONSOLIDATED BALANCE SHEET. THE PROVISION FOR LOSSES ON DOUBTFUL ACCOUNTS IS NOT REPORTED AS A SEPARATE LINE IN THE CONDENSED CONSOLIDATED STATEMENT OF INCOME OR STATEMENT OF CASH FLOWS. REPRESENTS BASIC EARNINGS PER SHARE. RESTATED TO REFLECT THE COMPANY'S ADOPTION OF FAS 128.
-----END PRIVACY-ENHANCED MESSAGE-----